Next, we separated these heterogeneous sub-clusters based on their types of PLC, finding the enrichment of abnormal metabolic processes in HCC sub-clusters (C1, C10, and C14), such as metabolism of isoprenoid, organic hydroxy compound, and monocarboxylic acid metabolism. The gene discussed is HSPG2; the disease is hepatocellular carcinoma.